Assoc Prof Toh Wei Seong

Assoc Prof Toh Wei Seong

Academic Appointment:
  • Associate Professor
    Department of Orthopaedic Surgery
    Yong Loo Lin School of Medicine
    National University of Singapore
  • Associate Professor (Joint)
    Faculty of Dentistry,
    National University of Singapore
  • Principal Investigator
    NUS Tissue Engineering Programme (NUSTEP)
    Life Science Institute
    National University of Singapore
  • Research Director
    Department of Orthopaedic Surgery
    Yong Loo Lin School of Medicine
    National University of Singapore
  • Associate Professor (Courtesy)
    Department of Biomedical Engineering
    College of Design and Engineering
    National University of Singapore
  • Supervisor
    Integrative Sciences and Engineering Program
    NUS Graduate School
    National University of Singapore
  • Post-Doc, Harvard Medical School, USA
  • PhD, National University of Singapore, Singapore
  • MSc, National University of Singapore, Singapore
  • BSc, University of Melbourne, Australia
  • World’s Top 2% Scientists, Stanford University, USA, 2020, 2021, 2022 and 2023
  • AUA Scholars Award, Asian Universities Alliance, 2019
  • Young Scientist Award, 9th World Biomaterials Congress, China, 2012
  • A*STAR International Fellowship Award, Agency for Science, Technology and Research (A*STAR) Singapore, 2010 – 2012
  • President Graduate Fellowship Award, National University of Singapore, Singapore, 2006 – 2010
  • Dental Science Poster Award, Combined Scientific Meeting, Singapore, 2005
  • NUS Research Scholarship, National University of Singapore, Singapore, 2004 – 2010
  • Research Summer Scholarship, Peter MacCallum Cancer Centre, Australia, 2003
  • Singapore Association for Medical Laboratory Science Prize, Singapore Polytechnic, Singapore, 1999
  • Musculoskeletal Research, Innovation and Translation
    • Our research activities are focused on understanding the mechanisms for degeneration, and developing strategies for regeneration, of tissues of the musculoskeletal system.
  • Rationally designed immunotherapeutics for joint disorder
  • Bioinspired nanovesicle immunotherapy for intervertebral disc degeneration
  • Translating MSC exosomes into pharmaceuticals
  • Exosome-infused device for enhanced spinal fusion
  • MSC exosomes: the next-generation MSC therapy for treatment of cartilage injuries